OR022 Tolerance of needleless subcutaneous immunotherapy in children

Pain, local reactions and the fear of anaphylaxis due to inadvertent intravenous administration limit the use of subcutaneous immunotherapy (SCIT) in children. We evaluate its tolerability when delivered by a needleless device.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Source Type: research